Enzo Biochem (NYSE: ENZ)
Some price data may be temporarily unavailable.
Enzo Biochem Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Enzo Biochem Company Info
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable customers to meet their clinical needs. It operates through the following segments: Products, Clinical Services, and Therapeutics. The Products segment develops, manufactures, and markets products to research and pharmaceutical customers. The Clinical Services segment provides diagnostic services to the health care community. The Therapeutics segment conducts research and development activities for therapeutic drug candidates. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.
News & Analysis
In Case You Missed it, This New Cancer Study is Terrifying
A terrifying new cancer study out of Johns Hopkins Medicine confirms a suspicion some researchers have harbored all along.
Enzo Biochem Earnings Preview
Enzo Biochem will unveil its latest earnings on Monday, Dec. 12.
Enzo Biochem Earnings Preview
Enzo Biochem will unveil its latest earnings on Wednesday, October 12.
Life Technologies Passes This Key Test
Look here for a clue.
6 Reasons to Worry About Next Week
Watch your step on the way down next week.
4-Star Stocks Poised to Pop: Isis Pharmaceuticals
Market-trouncing returns could be written in this 4-Star.
3 Stocks Ready to Roar
Investor sentiment is getting behind these stocks that are set to run.
The Wall Street Buy List
Actions speak louder than words.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.